{"transactions":[{"id":672930,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Option to Purchase Common Stock","published_at":"2026-08-28T20:51:17.000Z","date":"2026-08-28","kind":"grant","planned":false,"acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments."}],"balance_after":68000,"derivative":{"exercise_price":1.77,"expiration_date":"2036-08-27","underlying":"Common Stock","underlying_shares":68000},"source":{"system":"sec-edgar","filing":"0001540354-26-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035426000006/primary_doc.xml","form_type":"4"}},{"id":822807,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-04-01T20:01:06.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2458,"price":0.777,"value":1909.866,"ownership":{"direct":true},"balance_after":1080132,"source":{"system":"sec-edgar","filing":"0001540354-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035426000005/primary_doc.xml","form_type":"4"}},{"id":890643,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-02-20T19:15:19.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":71325,"price":0.68,"value":48501.0,"ownership":{"direct":true},"balance_after":1082590,"source":{"system":"sec-edgar","filing":"0001540354-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035426000004/primary_doc.xml","form_type":"4"}},{"id":951300,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-05T21:38:30.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":true,"shares":2458,"price":0.758,"value":1863.164,"ownership":{"direct":true},"balance_after":1153915,"source":{"system":"sec-edgar","filing":"0001540354-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035426000001/primary_doc.xml","form_type":"4"}},{"id":1029259,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-10-01T18:05:31.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2458,"price":0.8886,"value":2184.1788,"ownership":{"direct":true},"balance_after":1156373,"source":{"system":"sec-edgar","filing":"0001540354-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035425000009/primary_doc.xml","form_type":"4"}},{"id":1095112,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-07-02T14:42:06.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2458,"price":0.678,"value":1666.524,"ownership":{"direct":true},"balance_after":1158831,"source":{"system":"sec-edgar","filing":"0001540354-25-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035425000006/primary_doc.xml","form_type":"4"}},{"id":1168336,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2025-04-21T20:34:52.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on April 17, 2026, and the remaining 75% will vest in 12 equal quarterly installments."}],"balance_after":750000,"derivative":{"exercise_price":0.5796,"expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001540354-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035425000005/primary_doc.xml","form_type":"4"}},{"id":1176620,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-04-07T20:38:47.000Z","date":"2025-04-04","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.5,"value":50000.0,"ownership":{"direct":true},"balance_after":1161289,"source":{"system":"sec-edgar","filing":"0001540354-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035425000004/primary_doc.xml","form_type":"4"}},{"id":1183352,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-04-02T19:56:00.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2458,"price":0.8502,"value":2089.7916,"ownership":{"direct":true},"balance_after":1061289,"source":{"system":"sec-edgar","filing":"0001540354-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035425000003/primary_doc.xml","form_type":"4"}},{"id":1255667,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-02-20T21:05:17.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":71325,"price":1.16,"value":82737.0,"ownership":{"direct":true},"balance_after":1063747,"source":{"system":"sec-edgar","filing":"0001540354-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035425000002/primary_doc.xml","form_type":"4"}},{"id":1258922,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true}}],"security":"Stock Option","published_at":"2025-02-19T21:33:37.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":52632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 4,386 shares beginning on March 14, 2025 and continuing every month thereafter until fully vested."}],"balance_after":52632,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":52632},"source":{"system":"sec-edgar","filing":"0001021771-25-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000046/form4.xml","form_type":"4"}},{"id":1284760,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-02-04T18:33:11.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.15,"value":2574.85,"ownership":{"direct":true},"balance_after":1135072,"source":{"system":"sec-edgar","filing":"0001540354-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035425000001/primary_doc.xml","form_type":"4"}},{"id":1314647,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-03T20:39:40.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4697,"price":0.826,"value":3879.722,"ownership":{"direct":true},"balance_after":1137311,"source":{"system":"sec-edgar","filing":"0001213900-25-000714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390025000714/ownership.xml","form_type":"4"}},{"id":1344940,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-12-03T21:50:18.000Z","date":"2024-11-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.6231,"value":1395.1209,"ownership":{"direct":true},"balance_after":1142008,"source":{"system":"sec-edgar","filing":"0001540354-24-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000013/primary_doc.xml","form_type":"4"}},{"id":1378177,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-11-01T21:06:49.000Z","date":"2024-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.97,"value":2171.83,"ownership":{"direct":true},"balance_after":1144247,"source":{"system":"sec-edgar","filing":"0001540354-24-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000012/primary_doc.xml","form_type":"4"}},{"id":1394407,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-10-02T15:22:36.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":4697,"price":0.99,"value":4650.03,"ownership":{"direct":true},"balance_after":1146486,"source":{"system":"sec-edgar","filing":"0001540354-24-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000011/primary_doc.xml","form_type":"4"}},{"id":1415669,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-09-04T15:26:56.000Z","date":"2024-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.7964,"value":1783.1396,"ownership":{"direct":true},"balance_after":1151183,"source":{"system":"sec-edgar","filing":"0001540354-24-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000010/primary_doc.xml","form_type":"4"}},{"id":1442856,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-02T18:16:04.000Z","date":"2024-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.75,"value":1679.25,"ownership":{"direct":true},"balance_after":1153422,"source":{"system":"sec-edgar","filing":"0001540354-24-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000009/primary_doc.xml","form_type":"4"}},{"id":1462941,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-07-02T15:09:10.000Z","date":"2024-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":4697,"price":0.8,"value":3757.6,"ownership":{"direct":true},"balance_after":1155661,"source":{"system":"sec-edgar","filing":"0001540354-24-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000008/primary_doc.xml","form_type":"4"}},{"id":1492255,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-04T15:24:19.000Z","date":"2024-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.9299,"value":2082.0461,"ownership":{"direct":true},"balance_after":1160358,"source":{"system":"sec-edgar","filing":"0001540354-24-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000007/primary_doc.xml","form_type":"4"}},{"id":1530528,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-05-02T12:49:37.000Z","date":"2024-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.13,"value":2530.07,"ownership":{"direct":true},"balance_after":1162597,"source":{"system":"sec-edgar","filing":"0001540354-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000006/primary_doc.xml","form_type":"4"}},{"id":1536837,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-04-23T13:53:52.000Z","date":"2024-04-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":19673,"price":1.15,"value":22623.95,"ownership":{"direct":true},"balance_after":1164836,"source":{"system":"sec-edgar","filing":"0001540354-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000005/primary_doc.xml","form_type":"4"}},{"id":1553475,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-04-02T15:34:03.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.2,"value":2686.8,"ownership":{"direct":true},"balance_after":1184509,"source":{"system":"sec-edgar","filing":"0001540354-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000004/primary_doc.xml","form_type":"4"}},{"id":1578273,"issuer":{"id":7909,"kind":"organization","name":"Healthcare Triangle, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Option (Right To Buy)","published_at":"2024-03-13T17:00:03.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Incentive stock option granted 03/12/2024 under the Company's 2020 Stock Incentive Plan. All options expire within a 5-year period, with all 10,000 options vesting immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 26, 2023, the Issuer effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Split\"). Unless otherwise noted, the amount of securities and purchase prices reported on this Form 4 have been adjusted to reflect the Reverse Split."}],"balance_after":34000,"derivative":{"exercise_price":1.78,"exercise_date":"2024-03-12","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-022216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540354/000121390024022216/ownership.xml","form_type":"4"}},{"id":1602961,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-03-04T19:01:49.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.21,"value":2709.19,"ownership":{"direct":true},"balance_after":1186748,"source":{"system":"sec-edgar","filing":"0001540354-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000003/primary_doc.xml","form_type":"4"}},{"id":1629132,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-02-21T15:14:48.000Z","date":"2024-02-18","kind":"grant","planned":false,"acquired":true,"shares":663497,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 25% of the shares on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":1188987,"source":{"system":"sec-edgar","filing":"0001540354-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000002/primary_doc.xml","form_type":"4"}},{"id":1640658,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true}}],"security":"Stock Option","published_at":"2024-02-15T21:27:34.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":79646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing every month thereafter until fully vested."}],"balance_after":79646,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":79646},"source":{"system":"sec-edgar","filing":"0001021771-24-000056","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000056/form4.xml","form_type":"4"}},{"id":1663859,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-02-01T18:29:21.000Z","date":"2024-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.25,"value":2798.75,"ownership":{"direct":true},"balance_after":525490,"source":{"system":"sec-edgar","filing":"0001540354-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035424000001/primary_doc.xml","form_type":"4"}},{"id":1692312,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-01-03T18:29:06.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.58,"value":3537.62,"ownership":{"direct":true},"balance_after":527729,"source":{"system":"sec-edgar","filing":"0001213900-24-000530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024000530/ownership.xml","form_type":"4"}},{"id":1723800,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-12-04T21:09:02.000Z","date":"2023-11-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.45,"value":3246.55,"ownership":{"direct":true},"balance_after":529968,"source":{"system":"sec-edgar","filing":"0001540354-23-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000013/primary_doc.xml","form_type":"4"}},{"id":1743921,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T22:30:57.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":526303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on November 9, 2024, and the remaining 75% will vest in 36 equal monthly installments on the last day of each month following November 9, 2024."}],"balance_after":526303,"derivative":{"exercise_price":1.25,"expiration_date":"2033-11-08","underlying":"Common Stock","underlying_shares":526303},"source":{"system":"sec-edgar","filing":"0001540354-23-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000012/primary_doc.xml","form_type":"4"}},{"id":1749744,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-03T19:50:29.000Z","date":"2023-11-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.61,"value":3604.79,"ownership":{"direct":true},"balance_after":532207,"source":{"system":"sec-edgar","filing":"0001540354-23-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000011/primary_doc.xml","form_type":"4"}},{"id":1751304,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-11-02T19:56:50.000Z","date":"2023-10-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.9,"value":2015.1,"ownership":{"direct":true},"balance_after":534446,"source":{"system":"sec-edgar","filing":"0001540354-23-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000010/primary_doc.xml","form_type":"4"}},{"id":1767400,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-10-03T19:21:03.000Z","date":"2023-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.8904,"value":1993.6056,"ownership":{"direct":true},"balance_after":536685,"source":{"system":"sec-edgar","filing":"0001540354-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000009/primary_doc.xml","form_type":"4"}},{"id":1789163,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-09-05T15:25:43.000Z","date":"2023-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":0.8505,"value":1904.2695,"ownership":{"direct":true},"balance_after":538924,"source":{"system":"sec-edgar","filing":"0001540354-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000008/primary_doc.xml","form_type":"4"}},{"id":1819130,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-08-01T19:35:58.000Z","date":"2023-07-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.02,"value":2283.78,"ownership":{"direct":true},"balance_after":541163,"source":{"system":"sec-edgar","filing":"0001540354-23-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000007/primary_doc.xml","form_type":"4"}},{"id":1836104,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-07-05T17:49:43.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.2,"value":2686.8,"ownership":{"direct":true},"balance_after":543402,"source":{"system":"sec-edgar","filing":"0001540354-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000006/primary_doc.xml","form_type":"4"}},{"id":1871914,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-01T20:36:01.000Z","date":"2023-05-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.21,"value":2709.19,"ownership":{"direct":true},"balance_after":545641,"source":{"system":"sec-edgar","filing":"0001540354-23-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000005/primary_doc.xml","form_type":"4"}},{"id":1908276,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-05-02T19:29:17.000Z","date":"2023-04-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.54,"value":3448.06,"ownership":{"direct":true},"balance_after":547880,"source":{"system":"sec-edgar","filing":"0001540354-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000004/primary_doc.xml","form_type":"4"}},{"id":1914133,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2023-04-25T18:58:51.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":91500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024."}],"balance_after":91500,"derivative":{"exercise_price":1.59,"expiration_date":"2033-04-20","underlying":"Common Stock","underlying_shares":91500},"source":{"system":"sec-edgar","filing":"0001540354-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000003/primary_doc.xml","form_type":"4"}},{"id":1914132,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-04-25T18:58:51.000Z","date":"2023-04-21","kind":"grant","planned":false,"acquired":true,"shares":91500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date."}],"balance_after":550119,"source":{"system":"sec-edgar","filing":"0001540354-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000003/primary_doc.xml","form_type":"4"}},{"id":1928099,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-04-04T20:12:44.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2239,"price":1.61,"value":3604.79,"ownership":{"direct":true},"balance_after":458619,"source":{"system":"sec-edgar","filing":"0001540354-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000002/primary_doc.xml","form_type":"4"}},{"id":1952180,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-03-15T20:22:52.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":75930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the 2016 Equity Incentive Plan; with immediate vesting."}],"balance_after":474683,"derivative":{"exercise_price":1.94,"expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":75930},"source":{"system":"sec-edgar","filing":"0001493152-23-007760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315223007760/ownership.xml","form_type":"4"}},{"id":2006693,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-02-17T22:38:15.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":32028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing every month thereafter until fully vested."}],"balance_after":32028,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":32028},"source":{"system":"sec-edgar","filing":"0001567619-23-003334","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003334/doc1.xml","form_type":"4"}},{"id":2028407,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-02-07T21:18:08.000Z","date":"2023-02-03","kind":"tax_withholding","acquired":false,"shares":53750,"price":1.47,"value":79012.5,"ownership":{"direct":true},"balance_after":460858,"source":{"system":"sec-edgar","filing":"0001540354-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035423000001/primary_doc.xml","form_type":"4"}},{"id":2041895,"issuer":{"id":7909,"kind":"organization","name":"Healthcare Triangle, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T21:23:45.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.349,"exercise_date":"2023-01-27","expiration_date":"2028-01-27","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001607062-23-000041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540354/000160706223000041/ownership.xml","form_type":"4"}},{"id":2124214,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:18:04.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal, quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":10490,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019189","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019189/doc1.xml","form_type":"4"}},{"id":2124213,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-04T20:18:04.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal, quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019189","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019189/doc1.xml","form_type":"4"}},{"id":2162287,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-09-09T22:36:49.000Z","date":"2021-03-21","kind":"grant","acquired":true,"shares":31106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the 2016 Equity Incentive Plan; with immediate vesting."}],"balance_after":398753,"derivative":{"exercise_price":2.4,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":31106},"source":{"system":"sec-edgar","filing":"0001493152-22-025543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315222025543/ownership.xml","form_type":"4"}},{"id":2411669,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-02-04T23:26:30.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each month over the next 24 months, subject to continued service on such vesting date."}],"balance_after":514608,"source":{"system":"sec-edgar","filing":"0001540354-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035422000001/primary_doc.xml","form_type":"4"}},{"id":2485890,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-03T14:38:53.000Z","date":"2021-11-29","kind":"grant","acquired":true,"shares":27174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Granted in connection with the Reporting Person's service on the Company's board. Such shares were issued pursuant the Company's 2016 Equity Incentive Plan."}],"balance_after":152174,"source":{"system":"sec-edgar","filing":"0001493152-21-030377","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315221030377/ownership.xml","form_type":"4"}},{"id":2521127,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-11-08T22:42:16.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal, quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":10490,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-21-019510","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921019510/doc1.xml","form_type":"4"}},{"id":2543398,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T10:04:45.000Z","date":"2021-10-11","kind":"sale","acquired":false,"shares":3318,"price":3.05,"value":10119.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Company's 2016 Equity Incentive Plan."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001493152-21-025255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315221025255/ownership.xml","form_type":"4"}},{"id":2543397,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T10:04:45.000Z","date":"2021-10-08","kind":"sale","acquired":false,"shares":9481,"price":3.1994,"value":30333.5114,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Company's 2016 Equity Incentive Plan."}],"balance_after":128318,"source":{"system":"sec-edgar","filing":"0001493152-21-025255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315221025255/ownership.xml","form_type":"4"}},{"id":2543396,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T10:04:45.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":17228,"price":3.0833,"value":53119.0924,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Company's 2016 Equity Incentive Plan."}],"balance_after":137799,"source":{"system":"sec-edgar","filing":"0001493152-21-025255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315221025255/ownership.xml","form_type":"4"}},{"id":2546400,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2021-10-07T20:03:36.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 27, 2021, the reporting person was granted an option to purchase shares of common stock, 83,333 shares of which were subject to performance criteria, which performance criteria were met on May 26, 2021, resulting in the vesting of that portion of the option."}],"balance_after":416667,"derivative":{"exercise_price":5.97,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001540354-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000154035421000001/primary_doc.xml","form_type":"4"}},{"id":2556587,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T22:36:03.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":34977,"price":3.4284,"value":119915.1468,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Company's 2016 Equity Incentive Plan."}],"balance_after":155027,"source":{"system":"sec-edgar","filing":"0001493152-21-024126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315221024126/ownership.xml","form_type":"4"}},{"id":2556586,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-29T22:36:03.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":6246,"price":3.2695,"value":20421.297,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Company's 2016 Equity Incentive Plan."}],"balance_after":190004,"source":{"system":"sec-edgar","filing":"0001493152-21-024126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315221024126/ownership.xml","form_type":"4"}},{"id":2890276,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-29T21:49:53.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on January 27, 2022 and the remaining will vest in 36 equal monthly installments on the last day of each month beginning on February 28, 2022."}],"balance_after":1000000,"derivative":{"exercise_price":1.99,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001596771-21-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000159677121000005/primary_doc.xml","form_type":"4"}},{"id":3179001,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to purchase)","published_at":"2020-04-09T21:08:49.000Z","date":"2020-04-07","kind":"grant","acquired":true,"shares":367647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted in connection with the Reporting Person's service on the Company's board."}],"balance_after":367647,"derivative":{"exercise_price":0.98,"exercise_date":"2020-04-07","expiration_date":"2030-04-07","underlying":"Common Stock","underlying_shares":367647},"source":{"system":"sec-edgar","filing":"0001493152-20-006128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630113/000149315220006128/ownership.xml","form_type":"4"}},{"id":3377663,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Option to Purchase Common Stock","published_at":"2019-11-07T21:32:28.000Z","date":"2019-11-05","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on November 5, 2020 and the remaining 75% will vest in 36 equal monthly installments beginning on December 1, 2020."}],"balance_after":500000,"derivative":{"exercise_price":2.14,"expiration_date":"2029-11-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001596771-19-000134","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000159677119000134/primary_doc.xml","form_type":"4"}},{"id":4252609,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":18706,"kind":"person","name":"Rosa David A","position":1,"cik":"0001540354","reported_name":"Rosa David A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-07-24T20:28:48.000Z","date":"2017-07-20","kind":"grant","acquired":true,"shares":793822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired the shares of NeuroOne Medical Technologies Corporation (\"NMTC\") on July 20, 2017, in exchange for shares of common stock of NeuroOne, Inc. (\"NeuroOne\"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of July 20, 2017, between NMTC, OSOK Acquisition Company and NeuroOne, pursuant to which NeuroOne became the wholly-owned subsidiary of NMTC.  Per the terms of the Merger Agreement, each share of NeuroOne common stock was converted into the right to receive 17.0103706 shares of NMTC common stock."}],"balance_after":793822,"source":{"system":"sec-edgar","filing":"0001596771-17-000064","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000159677117000064/primary_doc.xml","form_type":"4"}}]}